Candid Therapeutics
PrivateLast Round
PIPE
Mar 2, 2026
Total Funding Raised
$370M
Momentum Score
25 /100
Company Overview
Candid Therapeutics is a biotechnology company focused on developing innovative, user-friendly therapies for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Candid Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Candid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Mar 2, 2026 | ||||
| Series A | Sep 9, 2024 |
Key People
Founding team and executive leadership
Candid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| Soleus Capital | Series A, PIPE |
| Janus Henderson Group | PIPE |
| RA Capital Management | PIPE |
| TCG Crossover | PIPE, Series A |
| LifeSci Venture Partners | Series A |
| Boxer Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
$505M raised in a PIPE round.
- Jan 14, 2026
Presenting at the 44th annual J.P. Morgan Healthcare Conference on January 14, 2026.
Candid Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Candid Therapeutics's valuation, stock price, and market status.
